Get started
Author

A.‐M. Stalfelt

Observed names: A. M. STALFELT, A. M. Stalfelt, A.-M. Stalfelt, A‐M Stalfelt, A‐M. Stalfelt
OpenAlex ID: A5113561869
Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone
1982 · K. Ideström, E. Kimby, et al. · European Journal of Cancer and Clinical Oncology · 53
High doses of natural α‐interferon (α‐IFN) in the treatment of multiple myeloma — A pilot study from the Myeloma Group of Central Sweden (MGCS)
1988 · A. Åhre, M. Björkholm, et al. · European Journal Of Haematology · 49
Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III —A randomized study from MGCS
1989 · A. Österborg, A. Ahre, et al. · European Journal Of Haematology · 38
Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myeloma
1983 · A. Åhre, M. Björkholm, et al. · European Journal of Cancer and Clinical Oncology · 28
Treatment of multiple myeloma with interferon alpha: the Scandinavian experience
1991 · H. Mellstedt, A. ÖSterborg, et al. · British Journal of Haematology · 24
A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia
1991 · C. Paul, U. Tidefelt, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 20
Long‐term follow‐up of patients ≥60 yr old with acute myeloid leukaemia treated with intensive chemotherapy
2002 · G. Öberg, A. Killander, et al. · European Journal Of Haematology · 19
Mitoxantrone, etoposide and ara‐C vs doxorubicin‐DNA, ara‐C, thioguanine, vincristine and prednisolone in the treatment of patients with acute myelocytic leukaemia. A randomized comparison
1995 · M. Björkholm, J. Liliemark, et al. · European Journal Of Haematology · 19
Costs over time in conventional treatment of acute myeloid leukaemia: A study exploring changes in treatment strategies over two decades
1994 · A. M. STALFELT, H. BRODIN · Journal of Internal Medicine · 16
Etoposide, doxorubicin, cyclophosphamide and high‐dose betamethasone (EACB) as outpatient salvage therapy for refractory multiple myeloma
1993 · M. Ohrling, M. Björkholm, et al. · European Journal Of Haematology · 11
Induction treatment with α‐interferon in multiple myeloma: An interim report from MGCS
1989 · H. Mellstedt, A. Österborg, et al. · European Journal Of Haematology · 9
Oral Versus Intravenous Melphalan and Prednisone Treatment in Multiple Myeloma Stage II: A randomized study from the Myeloma Group of Central Sweden
1990 · A. Österborg, A. Åhre, et al. · Acta Oncologica · 5
PDF
Quality of Life in Young Patients with Chronic Myelocytic Leukemia During Intensive Treatmen Including Interferon
1999 · A.‐M. Stalfelt, Olle Zettervall
Works count: 13
Citation count: 291
H-index: 10
I10-index: 10
Year
Topic
Type